Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
48
mentions
- X 34
- News 8
- Reddit 3
- YouTube 2
- +1 more
